Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stctc who wrote (2018)	8/17/2016 10:27:41 AM
From: eico20	Read Replies (1) of 2026

6 things in 2016 that could turn the tide for Vitaros 1. The new cold temp device with out of fridge duration and label of 7 days is starting to ship in EU 2. Approval in Mexico in 2016 for Ferring 3. Partner consolidation - Ferring has taken over Sandoz and Takeda, 2 partners that did not live up to the agreements, I wish they would take over Canada 4. Increasing sales in France, Spain and Italy 5. Launches by Recordati 6. NDA re-submission shortly after Nov. 17th Type B meeting with FDA - looks like a very strong package with efficacy and manufacturing issues resolved, and strong safety data now with close to 1.5M doses sold to date.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next